Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 93%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
44,227
Total Claims
$2.4M
Drug Cost
1,177
Beneficiaries
$2,001
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+11%
Opioid rate vs peers
2.5% vs 2.2% avg
+42%
Cost per patient vs peers
$2,001 vs $1,411 avg
+2%
Brand preference vs peers
10.8% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.5%
Opioid Rate
1,097
Opioid Claims
$30K
Opioid Cost
17.0%
Long-Acting Rate
Brand vs Generic
Brand: 4,779 claims · $1.8M
Generic: 39,269 claims · $575K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 852 | $301K |
| Empagliflozin | 167 | $139K |
| Semaglutide | 111 | $139K |
| Dapagliflozin Propanediol | 441 | $120K |
| Rivaroxaban | 315 | $107K |
| Tirzepatide | 69 | $78K |
| Sitagliptin Phosphate | 165 | $66K |
| Dulaglutide | 45 | $61K |
| Paliperidone Palmitate | 21 | $56K |
| Fluticasone/Umeclidin/Vilanter | 42 | $43K |
| Rifaximin | 53 | $41K |
| Linagliptin | 88 | $39K |
| Semaglutide | 34 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 71 | $34K |
| Evolocumab | 53 | $31K |
Prescribing Profile
Patient Profile
75
Avg Age
59%
Female
1.32
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About